Connect with us

General News

Kenya: Coronavirus Lockdown Now Spells Doom for Drug Industry

Published

6 years ago

on

[ad_1]

The coronavirus pandemic and measures to prevent its spread have disrupted the import and the flow of drugs into the country hence increasing a potential drug shortage.

The disease is exposing vulnerability in how Kenya gets its drugs, but potential backlogs really depend on the course of the virus.

According to a directive by the Ministry of Health, the country is likely to experience a huge shortage of the essential medicines – including paracetamol, cough syrup and antibiotics – if nothing is done.

How worried should Kenyans be? The answer largely depends on how long these disruptions continue in China and whether the outbreak becomes widespread in other countries critical to the drug supply chain, including India.

Tracking coronavirus

However, as China plans to lift the lockdown, there are hopes that things might get back to normal though it might take time.

With or without the pandemic, drug shortages are a perennial problem in Kenya. However, such a crisis can threaten to make things worse.

INDIA BAN

Figures seen by the Nation indicate 83 per cent of drugs consumed locally are imported, with only 17 per cent being manufactured in the country.

India supplies 35 per cent of Kenya’s imports. However, the country relies fully on China for active ingredients in antibiotics and heart medicines, among other drugs.

But fears of potential shortages have emerged again after India gazetted Wednesday a notification prohibiting with immediate effect the exportation of hydroxychloroquine and formulation made from hydroxychloroquine.

The notification, with the subject amendment in Export Policy of Hydroxychloroquine, said that the export will only be allowed to other countries on humanitarian grounds on a case basis on the recommendation of Ministry of External Affairs.

It also states that export will be allowed in case of shipment where Irrevocable Letter of Credit has been issued before the date of notification, or in case where full advance payment has been received by the exporter in India against the specific shipment, subject to the submission of documentary evidence.

DEMAND RISES

This is one of the drugs that the Kenya Medical Supplies Agency (Kemsa) had requested the Ministry of Health to clear them to purchase immediately the country recorded its first Covid-19 case in March 13.